External validation of exhaled breath profiling using an electronic nose in the discrimination of asthma with fixed airways obstruction and chronic obstructive pulmonary disease

Clinical and Experimental Allergy

Volumn 41, Issue 10, 2011, Pages 1371-1378

  Fens, N ^a   Roldaan, A C ^b   van der Schee, M P ^a   Boksem, R J ^a   Zwinderman, A H ^a   Bel, E H ^a   Sterk, P J ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b HAGA HOSPITAL   (Netherlands)

Author keywords

Asthma; COPD; Diagnostic accuracy; Electronic nose; Exhaled breath analysis; Fixed airways obstruction; Metabolomics; Persistent airflow limitation; Volatile organic compounds

Indexed keywords

ADULT; AGED; AIRWAY OBSTRUCTION; ALLERGY TEST; ARTICLE; ASTHMA; CHRONIC OBSTRUCTIVE LUNG DISEASE; CROSS-SECTIONAL STUDY; DIAGNOSTIC ACCURACY; ELECTRONICS; EXHALED BREATH PROFILING; EXPIRED AIR; EXTERNAL VALIDITY; FEMALE; HUMAN; LUNG FUNCTION TEST; MALE; METABOLOMICS; NOSE; PREDICTIVE VALUE; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; SMOKING;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AIRWAY OBSTRUCTION; ASTHMA; BREATH TESTS; CROSS-SECTIONAL STUDIES; DIAGNOSIS, DIFFERENTIAL; EXHALATION; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; MALE; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SENSITIVITY AND SPECIFICITY; VOLATILE ORGANIC COMPOUNDS; YOUNG ADULT;

EID: 80052969558     PISSN: 09547894     EISSN: 13652222     Source Type: Journal    
DOI: 10.1111/j.1365-2222.2011.03800.x     Document Type: Article

References (39)

1. Bateman ED, Hurd SS, Barnes PJet al. Global strategy for asthma management and prevention: GINA executive summary. Eur Respir J 2008; 31:143-78.
2. Rabe KF, Hurd S, Anzueto Aet al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2007; 176:532-55.
3. ten Brinke A, Zwinderman AH, Sterk PJ, Rabe KF, Bel EH.Factors associated with persistent airflow limitation in severe asthma. Am J Respir Crit Care Med 2001; 164:744-8.
4. Gibson PG, Simpson JL.The overlap syndrome of asthma and COPD: what are its features and how important is it? Thorax 2009; 64:728-35.
5. Bellia V, Battaglia S, Catalano Fet al. Aging and disability affect misdiagnosis of COPD in elderly asthmatics: the SARA study. Chest 2003; 123:1066-72.
6. Decramer M, Selroos O.Asthma and COPD: differences and similarities. With special reference to the usefulness of budesonide/formoterol in a single inhaler (Symbicort) in both diseases. Int J Clin Pract 2005; 59:385-98.
7. Contoli M, Baraldo S, Marku Bet al. Fixed airflow obstruction due to asthma or chronic obstructive pulmonary disease: 5-year follow-up. J Allergy Clin Immunol 2010; 125:830-7.
8. Diaz-Guzman E, Mannino DM.Airway obstructive diseases in older adults: from detection to treatment. J Allergy Clin Immunol 2010; 126:702-9.
9. Reed CE. Asthma in the elderly: diagnosis and management. J Allergy Clin Immunol 2010; 126:681-7.
10. Siva R, Green RH, Brightling CEet al. Eosinophilic airway inflammation and exacerbations of COPD: a randomised controlled trial. Eur Respir J 2007; 29:906-13.
11. Green RH, Brightling CE, Woltmann G, Parker D, Wardlaw AJ, Pavord ID.Analysis of induced sputum in adults with asthma: identification of subgroup with isolated sputum neutrophilia and poor response to inhaled corticosteroids. Thorax 2002; 57:875-9.
12. Fabbri LM, Romagnoli M, Corbetta Let al. Differences in airway inflammation in patients with fixed airflow obstruction due to asthma or chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2003; 167:418-24.
13. Di Lorenzo G, Mansueto P, Ditta Vet al. Similarity and differences in elderly patients with fixed airflow obstruction by asthma and by chronic obstructive pulmonary disease. Respir Med 2008; 102:232-8.
14. Van Berkel JJ, Dallinga JW, Möller GMet al. A profile of volatile organic compounds in breath discriminates COPD patients from controls. Respir Med 2010; 104:557-63.
15. Fens N, Zwinderman AH, van der Schee MPet al. Exhaled breath profiling enables discrimination of chronic obstructive pulmonary disease and asthma. Am J Respir Crit Care Med 2009; 180:1076-82.
16. Dragonieri S, Schot R, Mertens BJet al. An electronic nose in the discrimination of patients with asthma and controls. J Allergy Clin Immunol 2007; 120:856-62.
17. Montuschi P, Santonico M, Mondino Cet al. Diagnostic performance of an electronic nose, fractional exhaled nitric oxide, and lung function testing in asthma. Chest 2010; 137:790-6.
18. Pauling L, Robinson AB, Teranishi R, Cary P.Quantitative analysis of urine vapor and breath by gas-liquid partition chromatography. Proc Natl Acad Sci USA 1971; 68:2374-6.
19. Buszewski B, Kesy M, Ligor T, Amann A.Human exhaled air analytics: biomarkers of diseases. Biomed Chromatogr 2007; 21:553-66.
20. Gaspar EM, Lucena AF, Duro da CJ, Chaves das NH.Organic metabolites in exhaled human breath - a multivariate approach for identification of biomarkers in lung disorders. J Chromatogr A 2009; 1216:2749-56.
21. Friedrich MJ. Scientists seek to sniff out diseases: electronic "noses" may someday be diagnostic tools. JAMA 2009; 301:585-6.
22. Röck F, Barsan N, Weimar U.Electronic nose: current status and future trends. Chem Rev 2008; 108:705-2.
23. Bossuyt PM, Reitsma JB, Bruns DEet al. The STARD statement for reporting studies of diagnostic accuracy: explanation and elaboration. Ann Intern Med 2003; 138:W1-12.
24. Burney PG, Luczynska C, Chinn S, Jarvis D.The European Community Respiratory Health Survey. Eur Respir J 1994; 7:954-60.
25. Miller MR, Hankinson J, Brusasco Vet al. Standardisation of spirometry. Eur Respir J 2005; 26:319-38.
26. Crapo RO, Casaburi R, Coates ALet al. Guidelines for methacholine and exercise challenge testing-1999. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999. Am J Respir Crit Care Med 2000; 161:309-2.
27. Macintyre N, Crapo RO, Viegi Get al. Standardisation of the single-breath determination of carbon monoxide uptake in the lung. Eur Respir J 2005; 26:720-35.
28. Lewis NS. Comparisons between mammalian and artificial olfaction based on arrays of carbon black-polymer composite vapor detectors. Acc Chem Res 2004; 37:663-72.
29. Broadhurst DI, Kell DB.Statistical strategies for avoiding false discoveries in metabolomics and related experiments. Metabolomics 2006; 2:171-96.
30. Mauad T, Dolhnikoff M.Pathologic similarities and differences between asthma and chronic obstructive pulmonary disease. Curr Opin Pulm Med 2008; 14:31-8.
31. Anderson GP. Endotyping asthma: new insights into key pathogenic mechanisms in a complex, heterogeneous disease. Lancet 2008; 372:1107-19.
32. Chung KF, Adcock IM.Multifaceted mechanisms in COPD: inflammation, immunity, and tissue repair and destruction. Eur Respir J 2008; 31:1334-56.
33. Kharitonov SA, Barnes PJ.Exhaled biomarkers. Chest 2006; 130:1541-6.
34. Fens N, de Nijs SB, Peter S, Dekker T, Knobel HH, Vink TJ, Willard NP, Zwinderman AH, Krowels FH, Janssen H-G, Lutter R, Sterk PJ. Exhaled air molecular profiling in relation to inflammatory subtype and activity in COPD. Eur Respir J 2011; (accepted).
35. Dallinga JW, Robroeks CM, Van Berkel JJet al. Volatile organic compounds in exhaled breath as a diagnostic tool for asthma in children. Clin Exp Allergy 2010; 40:68-76.
36. Shaw DE, Berry MA, Hargadon Bet al. Association between neutrophilic airway inflammation and airflow limitation in adults with asthma. Chest 2007; 132:1871-5.
37. Knottnerus JA, Muris JW.Assessment of the accuracy of diagnostic tests: the cross-sectional study. J Clin Epidemiol 2003; 56:1118-22.
38. Shaham O, Carme L, Harel D.On mappings between electronic noses. Sensors Actuators B 2005; 106:76-82.
39. Lazar Z, Fens N, van der Maten Jet al. Electronic nose breathprints are independent of acute changes in airway caliber in asthma. Sensors 2010; 10:9127-38.